Skip to content

Evaluation of pregnancy success in infertile people with low ovarian reserve and less than 35 years old in IVF method with two different protocols.

Evaluation of the pregnancy outcome in the GnRH antagonist protocol with pretreatment in the luteal phase (including oral estradiol with or without GnRH antagonist) in comparison with the microdose GnRH agonist protocol in poor responder patients (Poseidon 3) in patients undergoing fertility treatment at the Milad Infertility Center.(randomized clinical trial)

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181030041503N8
Enrollment
105
Registered
2023-11-13
Start date
2023-11-22
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Complications of attempted introduction of embryo in embryo transfer

Interventions

Intervention 1: Intervention group: In the first group, from the 19th day of the previous cycle, oral estradiol is prescribed at a dose of 4 mg daily for 10 days. Gonadotropins start on the third day

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: Infertile women candidates for IVF under 35 years of age with regular cycles and low ovarian reserves (AMH<1.2 and AFC<5)

Exclusion criteria

Exclusion criteria: Male factor of infertility (severe), having moderate to severe endometriosis, having adenomyosis, or having uterine myoma other than subserous myoma with any syzymoma less than 4 cm, BMI>30

Design outcomes

Primary

MeasureTime frame
Total number of oocytes. Timepoint: Total number of M2 oocytes. Method of measurement: After picking up and laboratory examination.;Chemical pregnancy. Timepoint: n 2 week after embryo transfer. Method of measurement: BHCG.;The rate of clinical pregnancy. Timepoint: 6 weeks after embryo transfer. Method of measurement: Sonography.;Ongoing pregnancy. Timepoint: Continue pregnancy for up to 20 weeks. Method of measurement: Sonography.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmalihe mahmoudinia

Mashhad University of Medical Sciences

mahmoudiniam@mums.ac.ir+98 51 3853 4021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026